Loading page…
BioPorto A/S 2020 Annual Report
Company: BioPorto A/S
Sector: Professional & technical services
Country: Denmark
Year: 2020
Type: Annual Report
Pages: 75
The report describes BioPorto's response to COVID-19, including development of gRAD-based kidney and SARS-CoV-2 tests. NGALds obtained a CE mark while the COVID-19 test advanced to clinical evaluation. Two rights issues raised over DKK 130 million to support upcoming milestones, while group revenue was DKK 23.2 million versus DKK 26.6 million in 2019.
No standards or assurance data is available for this report.
Indicators available in this report:
No materiality data is available for this report.